Cite

HARVARD Citation

    Ros, J. et al. (2022). Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer. Therapeutic advances in gastroenterology. p. . [Online]. 
  
Back to record